Influenza M1 VLPs containing neuraminidase induce heterosubtypic cross-protection

被引:57
|
作者
Quan, Fu-Shi [3 ]
Kim, Min-Chul [4 ,5 ]
Lee, Byeong-Jae [4 ,5 ]
Song, Jae-Min [6 ]
Compans, Richard W. [4 ,5 ]
Kang, Sang-Moo [1 ,2 ]
机构
[1] Georgia State Univ, Ctr Inflammat Immun & Infect, Atlanta, GA 30303 USA
[2] Georgia State Univ, Dept Biol, Atlanta, GA 30303 USA
[3] Kyung Hee Univ, Dept Med Zool, Sch Med, Seoul 130701, South Korea
[4] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA
[5] Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA
[6] Sungshin Womens Univ, Dept Global Med Sci, Seoul, South Korea
关键词
Influenza; Virus-like particles; Neuraminidase; Protection; VIRUS-LIKE PARTICLES; INTRAVIRIONIC ANTIGENIC-COMPETITION; EXPRESSING H5 HEMAGGLUTININ; BROADENED IMMUNE-RESPONSE; A VIRUS; AVIAN INFLUENZA; LETHAL INFLUENZA; DENDRITIC CELLS; VIRAL NEURAMINIDASE; ANTIBODY-RESPONSE;
D O I
10.1016/j.virol.2012.05.006
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Influenza virus like particles (VLPs) containing hemagglutinin were previously demonstrated to induce protection against the homologous strains. However, little information is available on the protective role of neuraminidase (NA), the second major glycoprotein. In this study, we developed VLPs (NA VLPs) containing NA and M1 derived from A/PR/8/34 (H1N1) influenza virus, and investigated their ability to induce protective immunity. Intranasal immunization with NA VLPs induced serum antibody responses to H1N1 and H3N2 influenza A viruses as well as significant neuraminidase inhibition activity. Importantly, mice immunized with NA VLPs were 100% protected against lethal infection by the homologous A/PR/8/34 (H1N1) as well as heterosubtypic A/Philippines/82 (H3N2) virus, although body weight loss was observed after lethal challenge with heterosubtypic H3N2 virus. The present study therefore provides evidence that influenza VLPs containing M1 and NA are capable of inducing immunity to homologous as well as antigenically distinct influenza A virus strains. (C) 2012 Elsevier Inc. All rights reserved.
引用
收藏
页码:127 / 135
页数:9
相关论文
共 50 条
  • [21] Neuraminidase-Inhibiting Antibody Is a Correlate of Cross-Protection against Lethal H5N1 Influenza Virus in Ferrets Immunized with Seasonal Influenza Vaccine
    Rockman, Steven
    Brown, Lorena E.
    Barr, Ian G.
    Gilbertson, Brad
    Lowther, Sue
    Kachurin, Anatoly
    Kachurina, Olga
    Klippel, Jessica
    Bodle, Jesse
    Pearse, Martin
    Middleton, Deborah
    JOURNAL OF VIROLOGY, 2013, 87 (06) : 3053 - 3061
  • [22] Virus-Like Particles Containing the Tetrameric Ectodomain of Influenza Matrix Protein 2 and Flagellin Induce Heterosubtypic Protection in Mice
    Wang, Li
    Wang, Ying-Chun
    Feng, Hao
    Ahmed, Tamanna
    Compans, Richard W.
    Wang, Bao-Zhong
    BIOMED RESEARCH INTERNATIONAL, 2013, 2013
  • [23] Asymmetric Cross-Protection is Elicited by Distinct Influenza B Lineages
    Page, Caroline Katherine
    Shepard, Justin
    Ray, Sean
    Lorton, Ana T.
    Rowe, Dawne
    Tompkins, Stephen Mark
    JOURNAL OF IMMUNOLOGY, 2023, 210 (01):
  • [24] Cross-protection against influenza virus infection by intranasal administration of M1-based vaccine with chitosan as an adjuvant
    Sui, Zhiwei
    Chen, Quanjiao
    Fang, Fang
    Zheng, Mei
    Chen, Ze
    VACCINE, 2010, 28 (48) : 7690 - 7698
  • [25] A Live Attenuated H1N1 M1 Mutant Provides Broad Cross-Protection against Influenza A Viruses, Including Highly Pathogenic A/Vietnam/1203/2004, in Mice
    Xie, Hang
    Liu, Teresa M.
    Lu, Xiuhua
    Wu, Zhengqi
    Belser, Jessica A.
    Katz, Jacqueline M.
    Tumpey, Terrence M.
    Ye, Zhiping
    JOURNAL OF INFECTIOUS DISEASES, 2009, 200 (12): : 1874 - 1883
  • [26] Cross-protection studies with H5 influenza viruses
    Smirnov, YA
    Kaverin, NV
    Govorkova, EA
    Lipatov, AS
    Claas, ECJ
    Makarova, NV
    Gitelman, AK
    Webster, RG
    Lvov, DK
    OPTIONS FOR THE CONTROL OF INFLUENZA IV, 2001, 1219 : 767 - 773
  • [27] Vaccine approaches conferring cross-protection against influenza viruses
    Vemula, Sai V.
    Sayedahmed, Ekramy E.
    Sambhara, Suryaprakash
    Mittal, Suresh K.
    EXPERT REVIEW OF VACCINES, 2017, 16 (11) : 1141 - 1154
  • [28] Exploring cross-protection between influenza strains by an epidemiological model
    Lavenu, A
    Valleron, AJ
    Carrat, F
    VIRUS RESEARCH, 2004, 103 (1-2) : 101 - 105
  • [29] Neuraminidase antibodies and H5N1:: Geographic-dependent influenza epidemiology could determine cross-protection against emerging strains
    Bermejo-Martin, Jesus F.
    Kelvin, David J.
    Guan, Yi
    Chen, Honglin
    Perez-Brena, Pilar
    Casas, Inmaculada
    Arranz, Eduardo
    de Lejarazu, Raul O.
    PLOS MEDICINE, 2007, 4 (06): : 1130 - 1131
  • [30] Cross protection by inactivated recombinant influenza viruses containing chimeric hemagglutinin conjugates with a conserved neuraminidase or M2 ectodomain epitope
    Kim, Ki-Hye
    Jung, Yu-Jin
    Lee, Youri
    Park, Bo Ryoung
    Oh, Judy
    Lee, Yu-Na
    Kim, Min-Chul
    Jeeva, Subbiah
    Kang, Sang-Moo
    VIROLOGY, 2020, 550 : 51 - 60